Split-personality inhibitors

June 24th, 2021 by Carson C. Thoreen

Nature Chemical Biology, Published online: 24 June 2021; doi:10.1038/s41589-021-00820-8

A rationally designed class of mTORC1 inhibitors combines the selectivity of rapamycin with the potency of mTOR kinase inhibitors.